DE69104362D1 - Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen. - Google Patents

Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen.

Info

Publication number
DE69104362D1
DE69104362D1 DE69104362T DE69104362T DE69104362D1 DE 69104362 D1 DE69104362 D1 DE 69104362D1 DE 69104362 T DE69104362 T DE 69104362T DE 69104362 T DE69104362 T DE 69104362T DE 69104362 D1 DE69104362 D1 DE 69104362D1
Authority
DE
Germany
Prior art keywords
autobiotics
latentiated
cells
vivo elimination
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69104362T
Other languages
English (en)
Other versions
DE69104362T2 (de
Inventor
Laszlo Egyud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Research Corp
Original Assignee
Cell Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Research Corp filed Critical Cell Research Corp
Application granted granted Critical
Publication of DE69104362D1 publication Critical patent/DE69104362D1/de
Publication of DE69104362T2 publication Critical patent/DE69104362T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69104362T 1990-07-03 1991-07-01 Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen. Expired - Fee Related DE69104362T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/547,983 US5147652A (en) 1990-07-03 1990-07-03 Autobiotics and their use in eliminating nonself cells in vivo
PCT/US1991/004680 WO1992000727A1 (en) 1990-07-03 1991-07-01 Autobiotics and their use in eliminating nonself cells in vivo

Publications (2)

Publication Number Publication Date
DE69104362D1 true DE69104362D1 (de) 1994-11-03
DE69104362T2 DE69104362T2 (de) 1995-05-18

Family

ID=24186953

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69104362T Expired - Fee Related DE69104362T2 (de) 1990-07-03 1991-07-01 Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen.

Country Status (9)

Country Link
US (1) US5147652A (de)
EP (1) EP0537267B1 (de)
JP (1) JPH06501680A (de)
AT (1) ATE112161T1 (de)
AU (1) AU8216691A (de)
CA (1) CA2086513A1 (de)
DE (1) DE69104362T2 (de)
ES (1) ES2065698T3 (de)
WO (1) WO1992000727A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260341A (en) * 1992-07-14 1993-11-09 Agro-K Corporation Inc. Product and process for treating bovine mastitis and bovine metritis
AU723585B2 (en) * 1996-03-28 2000-08-31 Trustees Of Boston University Methods of modulating melanin synthesis
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
IT1318424B1 (it) * 2000-03-24 2003-08-25 Unihart Corp Composti con attivita' anti-hiv.
US6596755B2 (en) * 2001-07-02 2003-07-22 Dabur Research Foundation Oral formulation of methylglyoxal and its imino acid conjugates for human use
GB0125659D0 (en) * 2001-10-25 2001-12-19 Ssl Int Plc Spermicides
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2514841A1 (en) * 2003-02-02 2004-08-19 Palo Alto Institute Of Molecular Medicine Cell-killing molecules and methods of use thereof
US20040171175A1 (en) * 2003-02-28 2004-09-02 Swanson Basil I. Process for conjugating biomolecules to hydrophobic membrane-incorporated molecules
WO2016057699A1 (en) 2014-10-07 2016-04-14 Kinsella Timothy J METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER WITH 5-IODO-2-PYRIMIDINONE-2'-DEOXYRIBOSE (IPdR)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066650A (en) * 1971-02-11 1978-01-03 Egyud Laszlo G Keto-aldehyde-amine addition products and method of making same
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4440740A (en) * 1982-04-26 1984-04-03 Merck & Co., Inc. α-Keto aldehydes as enhancing agents of gastro-intestinal drug absorption
DE3218121A1 (de) * 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
CA1270198C (en) * 1984-08-08 1990-06-12 Marcel B Bally ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
DE3682257D1 (de) * 1985-11-22 1991-12-05 Takeda Chemical Industries Ltd Liposomzusammensetzung.
JPH0825869B2 (ja) * 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤

Also Published As

Publication number Publication date
ATE112161T1 (de) 1994-10-15
WO1992000727A1 (en) 1992-01-23
CA2086513A1 (en) 1992-01-04
US5147652A (en) 1992-09-15
EP0537267A1 (de) 1993-04-21
ES2065698T3 (es) 1995-02-16
DE69104362T2 (de) 1995-05-18
EP0537267B1 (de) 1994-09-28
AU8216691A (en) 1992-02-04
JPH06501680A (ja) 1994-02-24

Similar Documents

Publication Publication Date Title
DE69104362D1 (de) Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen.
CA2067541A1 (en) Reduction products of rapamycin
ZA914456B (en) Treatment of organ transplantation rejection
DK0513409T3 (da) Anvendelse af et mikrobicidt middel ved fremstilling af betontagsten
IT9019101A1 (it) Procedimento per la stabilizzazione particolarmente di mosto d'uva.
ES2103825T3 (es) Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.
DE69013871D1 (de) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
DE69114252D1 (de) Reveromycin-a, herstellung und verwendung als antitumormittel sowie als fungizid.
GR3017967T3 (en) Substituted pyrido-oxazines.
DE60045750D1 (de) E5564 zur Verwendung in der Behandlung von Allograft-Abstossung oder Host-versus-Graft-Erkrankungen
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
DE59006283D1 (de) Alternierende Copolymere, Verfahren zu ihrer Herstellung sowie deren Verwendung.
DE69023331T2 (de) Behandeltes hämoglobin und dessen herstellung.
ES2059859T3 (es) Medicamento y su empleo para tratamiento de parasitos.
IT231746Y1 (it) Attrezzo atto ad evitare al degente la caduta dai bordi laterali del letto
IT1237514B (it) Composti ad attivita' antitussiva, processo per la loro preparazione, loro composizioni farmaceutiche.
IT9046893A0 (it) Procedimento e impianto per la lavorazione del pomodoro e di simili frutti da polpa
ITBO930016A0 (it) Procedimento per la lavorazione elettrochimica di pezzi metallici lastriformi.
ES1011387Y (es) Protesis para el tratamiento y recuperacion de miembros inferiores.
ITRM920298A0 (it) Composizione e procedimento per la produzione di lastre acriliche termoformabili per articoli sanitari.
ITRM920338A1 (it) Perfezionamento nei processi di pelatura dei pomidoro e di frutti simili, e mezzi per l'attuazione di questo perfezionamento.
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.
ES1014529Y (es) Equipo portatil para tratamiento prehospitalario de urgencias medicas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee